Eagle Asset Management’s STAAR Surgical STAA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-157,424
Closed -$10.1M 570
2023
Q1
$10.1M Sell
157,424
-89,559
-36% -$5.85M 0.06% 249
2022
Q4
$12.7M Sell
246,983
-10,573
-4% -$663K 0.08% 207
2022
Q3
$18.2M Buy
257,556
+60,247
+31% +$5.16M 0.12% 177
2022
Q2
$14M Sell
197,309
-51,061
-21% -$3.29M 0.09% 209
2022
Q1
$19.8M Buy
248,370
+12,354
+5% +$920K 0.1% 198
2021
Q4
$22.1M Sell
236,016
-3,886
-2% -$417K 0.1% 209
2021
Q3
$30.8M Sell
239,902
-623
-0.3% -$87.2K 0.14% 185
2021
Q2
$36.7M Buy
+240,525
New +$31.7M 0.16% 182

Other funds holding STAA

Eagle Asset Management's STAA Position: Q2 2023 in Review

Eagle Asset Management sold out of STAAR Surgical (STAA) in Q2 2023, closing a stake of 157,424 shares — an estimated $10.1M sold.

Eagle Asset Management first reported a position in STAA in Q2 2021 and held it in 8 quarters. The position peaked at $36.7M in Q2 2021. 245 funds tracked by Wall St. Rank hold STAA as of Q2 2023.

  • Eagle Asset Management reported no remaining STAAR Surgical position as of Q2 2023 after selling out during the quarter.
  • Eagle Asset Management sold 157,424 STAAR Surgical shares in Q2 2023, an estimated $10.1M.
  • Eagle Asset Management first reported a position in STAAR Surgical in Q2 2021 and held it in 8 quarters.
  • Eagle Asset Management's STAAR Surgical position peaked at $36.7M in Q2 2021.
  • 245 funds tracked by Wall St. Rank held STAAR Surgical as of Q2 2023.

Based on Eagle Asset Management's 13F filing for Q2 2023, filed 9 Aug 2023.